Jay M. Lee
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
- Oncology 40
- Cancer Immunotherapy and Biomarkers 22
- Cytokine Signaling Pathways and Interactions 6
- Chemokine receptors and signaling 6
-
- Lung Cancer Diagnosis and Treatment 23
- Lung Cancer Treatments and Mutations 20
- Co-authors
- Sherven Sharma (21 shared papers)Steven M. Dubinett (25 shared papers)Edward B. Garon (17 shared papers)Jane Yanagawa (20 shared papers)David Elashoff (11 shared papers)Minu K. Srivastava (7 shared papers)Li Zhu (5 shared papers)David T. Wong (2 shared papers)
- Journals
- Journal of Clinical Oncology (11 papers)Cancer Research (6 papers)Journal of Thoracic Oncology (5 papers)Future Oncology (3 papers)The Annals of Thoracic Surgery (3 papers)
- Partner nations
- United StatesSwitzerlandJapan
In The Last Decade
Jay M. Lee
86 papers receiving 2.1k citations
Peers
Comparison fields: 5 of 101
- Oncology 787
- Immunology 537
- Pulmonary and Respiratory Medicine 531
- Periodontics 71
- Cancer Research 212
Countries citing papers authored by Jay M. Lee
This map shows the geographic impact of Jay M. Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay M. Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay M. Lee more than expected).
Fields of papers citing papers by Jay M. Lee
This network shows the impact of papers produced by Jay M. Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay M. Lee. The network helps show where Jay M. Lee may publish in the future.
Co-authors
The 25 scholars most cited alongside Jay M. Lee, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 93 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 180 | |
| 2 | 2011 | 162 | |
| 3 | 2012 | 140 | |
| 4 | 2019 | 107 | |
| 5 | 2009 | 105 | |
| 6 | 2008 | 105 | |
| 7 | 2017 | 84 | |
| 8 | 2012 | 82 | |
| 9 | 2013 | 67 | |
| 10 | 2007 | 65 | |
| 11 | PGE(2) contributes to TGF-beta induced T regulatory cell function in human non-small cell lung cancer. | 2010 | 60 |
| 12 | 2014 | 50 | |
| 13 | 2008 | 46 | |
| 14 | 2023 | 42 | |
| 15 | 2008 | 42 | |
| 16 | 2018 | 40 | |
| 17 | 2012 | 36 | |
| 18 | 2010 | 34 | |
| 19 | 2021 | 32 | |
| 20 | 2001 | 32 |
About Jay M. Lee
Jay M. Lee is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Immunology, Surgery and Cancer Research, having authored 93 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (23 papers), Cancer Immunotherapy and Biomarkers (22 papers), Lung Cancer Treatments and Mutations (20 papers), Immunotherapy and Immune Responses (10 papers), Immune cells in cancer (7 papers), Cytokine Signaling Pathways and Interactions (6 papers), Chemokine receptors and signaling (6 papers) and Cancer Genomics and Diagnostics (5 papers). The work is most often cited by research in Oncology (787 citations), Immunology (537 citations), Pulmonary and Respiratory Medicine (531 citations), Periodontics (71 citations) and Cancer Research (212 citations). Jay M. Lee has collaborated with scholars based in United States, Switzerland and Japan. Frequent co-authors include Sherven Sharma, Steven M. Dubinett, Edward B. Garon, Jane Yanagawa, David Elashoff, Minu K. Srivastava, Li Zhu, David T. Wong, Hua Xiao and Marni E. Harris‐White. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Journal of Thoracic Oncology, Future Oncology and The Annals of Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.